Description

1-Piperazinecarboxamide,n-(4-Ethoxyphenyl)-4-(1-Methyl-1H-Benzimidazol-2-Yl)-(9Ci) is a high-purity, advanced pharmaceutical intermediate of significant interest in modern organic synthesis. This compound matters for its role as a critical building block in the development of novel active pharmaceutical ingredients (APIs), particularly those targeting specific receptor pathways. Pharmaceutical R&D laboratories and fine chemical manufacturers need this precise chemical entity to support the synthesis of potential therapeutic agents, ensuring process reliability and product quality from early development to scale-up.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Biochemical Research: Used as a reference standard or building block in medicinal chemistry programs for structure-activity relationship (SAR) studies.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis and process development projects.
• Academic Research: Utilized in university and institutional laboratories for exploratory synthetic chemistry and pharmacological research.
• API Synthesis: Incorporated into multi-step synthetic routes for the production of complex target molecules in the pharmaceutical pipeline.

Basic Information

Item	Details
Product Name	1-Piperazinecarboxamide,n-(4-Ethoxyphenyl)-4-(1-Methyl-1H-Benzimidazol-2-Yl)-(9Ci)
CAS No.	604741-52-8
Molecular Formula	C21H25N5O2
Molecular Weight	379.46 g/mol
Synonyms	N-(4-Ethoxyphenyl)-4-(1-methyl-1H-benzimidazol-2-yl)piperazine-1-carboxamide; 4-(1-Methyl-1H-benzimidazol-2-yl)-N-(4-ethoxyphenyl)piperazine-1-carboxamide; UNII-9J3Y4B8Y6F; 1-Piperazinecarboxamide, N-(4-ethoxyphenyl)-4-(1-methyl-1H-benzimidazol-2-yl)-; 604741-52-8; 9CI; SCHEMBL15505527; AKOS025147213
EINECS	Contact for details

Quality Control

Our 1-Piperazinecarboxamide,n-(4-Ethoxyphenyl)-4-(1-Methyl-1H-Benzimidazol-2-Yl)-(9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure compliance with exacting standards for pharmaceutical intermediates. Certificates of Analysis (COA) detailing batch-specific results are available upon request to support your quality assurance and regulatory documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. Due to its light-sensitive nature, handling and packaging should minimize exposure to direct light.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single unknown impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.